Home>Topics>Funds>Biotech HOLDRs

Biotech HOLDRs BBH

  1. All
  2. Commentary
  3. Video Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Fitch Affirms All Ratings for Bank of New York, Northern, & Brown Brothers; Upgrades State Street

      Headlines

      Thu, 14 Aug 2014

      Mellon Corporation (BONY) at 'AA-', Northern Trust Corporation (Northern) at 'AA-', and Brown Brothers Harriman ( BBH ) at 'A+'. The Rating Outlook for BONY, Northern, and Brown Brothers remains Stable. In addition, Fitch has upgraded

    2. Dynamic And Durable Growth (Part 1)

      Headlines

      Thu, 24 Jul 2014

      By Invesco : By Janet Luby Part 1: A Biotech/Pharma Revolution This is the first in a four-part series examining dynamic and durable growth themes that affect the U.S. economy and may present opportunities for investors. The remaining three blog posts will examine the enormous implications of shale

    3. Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

      Headlines

      Mon, 21 Jul 2014

      By DoctoRx : Background : When the Fed noted some froth in "smaller" biotechs last week, large ones also got slammed. Biogen Idec (NASDAQ: BIIB ) fell more than 7% after that statement. Gilead Sciences (NASDAQ: GILD ) fell 5% peak-to-trough. Small ones got dumped big-time. Is it but a passing ...

    4. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

      Headlines

      Tue, 3 Jun 2014

      with Timothy Hartch and Michael Keller at BBH Core Select BBTEX "> BBTEX making a high ..... s common stock. While the managers at BBH Select Core also put a little bit of money ..... during our last article , the managers at BBH Core Select made a high-conviction new

    5. 10 High-Conviction Purchases of Ultimate Stock-Pickers

      Headlines

      Tue, 20 May 2014

      Appreciation. The fund has been replaced with BBH Core Select BBTEX, which our fund team ..... characteristics with the manager it was replacing. BBH Core Select's managers--Tim Hartch ..... the team's valuation work. We expect BBH Core Select to be a solid addition to the

    6. IBB iShares Nasdaq Biotechnology ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech XBI and Market Vectors Biotech ETF BBH charge just 0.35%. Still, we think ..... 0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is ..... Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an

    7. XBI SPDR S&P Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech & Genome PBE (0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is more of a traditional ..... think Amgen, Gilead, Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an average market cap

    8. FBT First Trust NYSE Arca Biotech Index ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech & Genome PBE (0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is more of a traditional ..... think Amgen, Gilead, Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an average market cap

    9. Need to change this for retirement. Any suggestions???

      Commentary

      Wed, 18 Dec 2013

      Would like around a 5% + return. AKRE FOCUS FUND RETAIL 5 522 shares BBH CORE SELECT FUND CL N 5 605 " BERWYN INCOME FUND 1694 " BUFFALO FLEXIBLE INCOME FUND 360 " BUFFALO DISCOVERY FUND 320 " BECKER

    10. Zacks.com

      Commentary

      Sat, 7 Dec 2013

      ETFs, Financials, and two Small Cap ETFs came up also but the big category turned out to be HealthCare. IBB at 12.23%, BBH up 11.71% and XBI up 12.21% to name a few. I counted 12 ETFs up over 6% in the 1 Mon (%). I'm wondering if what

    « Prev12345Next »
    Content Partners